David J. Brillon

2.7k total citations · 1 hit paper
27 papers, 1.3k citations indexed

About

David J. Brillon is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology and Molecular Biology. According to data from OpenAlex, David J. Brillon has authored 27 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Physiology and 6 papers in Molecular Biology. Recurrent topics in David J. Brillon's work include Diabetes Management and Research (10 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers) and Diabetes Treatment and Management (5 papers). David J. Brillon is often cited by papers focused on Diabetes Management and Research (10 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers) and Diabetes Treatment and Management (5 papers). David J. Brillon collaborates with scholars based in United States, Canada and Australia. David J. Brillon's co-authors include Dwight E. Matthews, Robert G. Campbell, Patricia A. Cleary, David M. Nathan, Trevor J. Orchard, Bernard Zinman, Jye‐Yu C. Backlund, John M. Lachin, Bisheng Zheng and Duygu Onat and has published in prestigious journals such as JAMA, Annals of Internal Medicine and American Journal of Clinical Nutrition.

In The Last Decade

David J. Brillon

27 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Association Between 7 Years of Intensive Treatment of Type 1 Diabetes and Long-term Mortality

2015 303 citations Trevor J. Orchard, David M. Nathan et al. JAMA profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David J. Brillon United States	14	746	294	252	235	197	27	1.3k
Christian Djurhuus Denmark	17	641 0.9×	274 0.9×	431 1.7×	295 1.3×	234 1.2×	29	1.4k
Arnold H. Slyper United States	18	358 0.5×	401 1.4×	279 1.1×	175 0.7×	292 1.5×	42	1.3k
W P Pimenta Brazil	14	673 0.9×	373 1.3×	266 1.1×	341 1.5×	219 1.1×	29	1.1k
Shin Amemiya Japan	18	754 1.0×	223 0.8×	160 0.6×	367 1.6×	509 2.6×	57	1.3k
Zdravko Kamenov Bulgaria	20	509 0.7×	298 1.0×	271 1.1×	134 0.6×	104 0.5×	130	1.7k
Alexandre Wajngot Sweden	19	593 0.8×	431 1.5×	374 1.5×	412 1.8×	164 0.8×	40	1.2k
Bruno Schisano Italy	14	472 0.6×	288 1.0×	196 0.8×	163 0.7×	74 0.4×	15	1.1k
Kyung Wan Min South Korea	24	968 1.3×	449 1.5×	383 1.5×	339 1.4×	66 0.3×	98	1.8k
Igor Tauveron France	27	851 1.1×	355 1.2×	223 0.9×	624 2.7×	160 0.8×	103	1.9k
V. Bähr Germany	28	1.4k 1.8×	404 1.4×	157 0.6×	294 1.3×	244 1.2×	68	2.1k

Countries citing papers authored by David J. Brillon

Since Specialization

Citations

This map shows the geographic impact of David J. Brillon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Brillon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Brillon more than expected).

Fields of papers citing papers by David J. Brillon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. Brillon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Brillon. The network helps show where David J. Brillon may publish in the future.

Co-authorship network of co-authors of David J. Brillon

This figure shows the co-authorship network connecting the top 25 collaborators of David J. Brillon. A scholar is included among the top collaborators of David J. Brillon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David J. Brillon. David J. Brillon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Orchard, Trevor J., David M. Nathan, Bernard Zinman, et al.. (2015). Association Between 7 Years of Intensive Treatment of Type 1 Diabetes and Long-term Mortality. JAMA. 313(1). 45–45. 303 indexed citations breakdown →

Punthakee, Zubin, Michael E. Miller, Debra L. Simmons, et al.. (2014). Durable change in glycaemic control following intensive management of type 2 diabetes in the ACCORD clinical trial. Diabetologia. 57(10). 2030–2037. 6 indexed citations

Flory, James, Dylan S. Small, Patricia A. Cassano, et al.. (2013). Comparative effectiveness of oral diabetes drug combinations in reducing glycosylated hemoglobin. Journal of Comparative Effectiveness Research. 3(1). 29–39. 15 indexed citations

Shukla, Alpana P., Greg Dakin, Alfons Pomp, et al.. (2012). Medical versus surgical treatment of type 2 diabetes: the search for level 1 evidence. Surgery for Obesity and Related Diseases. 8(4). 476–482. 7 indexed citations

Light, Laney S., David J. Brillon, James V. Felicetta, et al.. (2012). Diabetes Control Among Hispanics in the Action to Control Cardiovascular Risk in Diabetes Trial. Journal of General Internal Medicine. 27(11). 1499–1505. 7 indexed citations

Onat, Duygu, David J. Brillon, P.C. Colombo, & Ann Marie Schmidt. (2011). Human Vascular Endothelial Cells: A Model System for Studying Vascular Inflammation in Diabetes and Atherosclerosis. Current Diabetes Reports. 11(3). 193–202. 157 indexed citations

Andrés, R., et al.. (2010). Hemoglobin A1C Criterion for Diabetes Diagnosis Among Hispanic and Non-Hispanic Populations. Endocrine Practice. 17(2). 210–217. 11 indexed citations

Riddle, Matthew C., Walter T. Ambrosius, David J. Brillon, et al.. (2010). Epidemiologic Relationships Between A1C and All-Cause Mortality During a Median 3.4-Year Follow-up of Glycemic Treatment in the ACCORD Trial. Diabetes Care. 33(5). 983–990. 292 indexed citations

Bang, Heejung, Alison Edwards, Andrew S. Bomback, et al.. (2009). A patient self-assessment diabetes screening score:: development, validation, and comparison to other diabetes risk assessment scores. Annals of Internal Medicine. 151(11). 775. 16 indexed citations

10.

Poretsky, Leonid, David J. Brillon, Stephen J. Ferrando, et al.. (2008). Metabolic and Hormonal Effects of Oral DHEA in Premenopausal Women with HIV Infection: A Randomized, Prospective, Placebo-controlled Pilot Study. Hormone and Metabolic Research. 41(3). 244–249. 8 indexed citations

11.

Bonds, Denise E., Richard M. Bergenstal, David J. Brillon, et al.. (2007). Severe Hypoglycemia Monitoring and Risk Management Procedures in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial. The American Journal of Cardiology. 99(12). S80–S89. 44 indexed citations

12.

Kern, Lisa M., et al.. (2006). Glucose testing and insufficient follow-up of abnormal results: a cohort study. BMC Health Services Research. 6(1). 87–87. 13 indexed citations

13.

Brillon, David J., et al.. (2006). Reproducibility of a Glycemic Response to Mixed Meals in Type 2 Diabetes Mellitus. Hormone and Metabolic Research. 38(8). 536–542. 1 indexed citations

14.

Poretsky, Leonid, David J. Brillon, Stephen J. Ferrando, et al.. (2006). Endocrine effects of oral dehydroepiandrosterone in men with HIV infection: a prospective, randomized, double-blind, placebo-controlled trial. Metabolism. 55(7). 858–870. 12 indexed citations

15.

Poretsky, Leonid, Martin Lesser, & David J. Brillon. (2001). Lack of postprandial leptin peaks in patients with type 2 diabetes mellitus. Diabetes Obesity and Metabolism. 3(2). 105–111. 8 indexed citations

16.

Matthews, Dwight E., et al.. (1999). Splanchnic bed utilization of enteral α-ketoisocaproate in humans. Metabolism. 48(12). 1555–1563. 15 indexed citations

17.

Battezzati, Alberto, Michael Haisch, David J. Brillon, & Dwight E. Matthews. (1999). Splanchnic utilization of enteral alanine in humans. Metabolism. 48(7). 915–921. 17 indexed citations

18.

Ratheiser, Klaus, David J. Brillon, Robert G. Campbell, & Dwight E. Matthews. (1998). Epinephrine produces a prolonged elevation in metabolic rate in humans. American Journal of Clinical Nutrition. 68(5). 1046–1052. 38 indexed citations

19.

Olefsky, Jerrold M., et al.. (1988). Cellular mechanisms of insulin resistance in non-insulin-dependent (type II) diabetes. The American Journal of Medicine. 85(5). 86–105. 66 indexed citations

20.

Brillon, David J., Robert R. Henry, Harald Klein, Jerrold M. Olefsky, & Gary R. Freidenberg. (1988). Functional and Structural Differences in Human and Rat-Derived Insulin Receptors: Characterization of the β-Subunit Kinase Activity*. Endocrinology. 123(4). 1837–1847. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact